Glycated haemoglobin (HDbA1c) monitoring

British Medical Journal

Volumn 333, Issue 7568, 2006, Pages 586-588

  Reynolds, Timothy M ^a   Smellie, W Stuart A ^b   Twomey, Patrick J ^c  

^a QUEEN S HOSPITAL   (United Kingdom)

^b BISHOP AUCKLAND GENERAL HOSPITAL   (United Kingdom)

^c IPSWICH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCOSYLATED HEMOGLOBIN; METFORMIN; SULFONYLUREA;

ADULT; ANAMNESIS; ARTICLE; BLOOD GLUCOSE MONITORING; CASE REPORT; CLINICAL FEATURE; DIABETES MELLITUS; DRUG DOSE REGIMEN; ERYTHROCYTE LIFESPAN; FEMALE; HUMAN; HYPERTENSION; LABORATORY TEST; MALE; MICROALBUMINURIA; MONITORING; NUTRITIONAL ASSESSMENT; PATIENT MONITORING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; BLOOD; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; REVIEW;

DIABETES MELLITUS, TYPE 2; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED;

EID: 33748934023     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38947.627847.AE     Document Type: Article

References (15)

1. Goldstein DE, Little RR, Lorenz RA, Malone RI, Nathan D, Petereson CM. Tests of glycemia in diabetes. Diabetes Care 1985;18:896-909.
2. Beach KW A theoretical model to predict the behavior of glycosylated hemoglobin levels. J Theor Biol 1979;81:547-61.
3. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes management on macrovascular events and risk factors in me diabetes control and complications trial. Am J Cardiol 1995;75:894-903.
4. European Diabetes Policy Group. A desktop guide to type 2 diabetes mellitus. Diabet Med 1999;16:716-30.
5. American College of Endocrinology consensus statement on guidelines for glycemic control. Endocrine Practice 2002;8(suppl 1).
6. National Institute for Health and Clinical Excellence. Type 1 diabetes: diagnosis and management of type 1 diabetes in adults. Clinical guideline 15, full guideline, main section. www.nice.org.uk/pdf/cg015_full guideline_adults_main_section.pdf (accessed 3 Oct 2005).
7. National Institute for Health and Clinical Excellence. Management of type 2 diabetes-managing blood glucose levels. Guideline G. www.nice.org.uk/pdf/ NICE_INHERITEG_guidelines.pdf (accessed 3 Oct 2005).
8. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 2005;28(suppl 1):S4-36.
9. Department of Health. National service framework for diabetes: standards. Download intervention details and draft service models. March 2002. www.dh.gov.uk/assetRoot/04/UV28/42/04032842.pdf (accessed 30 August 2006).
10. NHS Confederation. Quality and outcomes framework. Accompanying guidance document. 2003. www.nhsconfed.org/docs/quality_and_ outcomes_framework_guidance. pdf (accessed 3 Oct 2005).
11. NHS Employers. Revisions to the GMS contract 2006/7. www.nhsemployers. org/primary/index.cfm (accessed 3 May 2006).
12. 1c in the diabetes control and complications trial. Diabetes Care 2002;25:275-8.
13. Smellie WSA, Forth J, Bareford D, Twomey P, Galloway MJ, Logan ECM, et al. Best practice in primary care pathology: review 3. J Clin Pathol 2006;59:781-9.
14. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998;352:837-53.
15. 1c measurement. J Clin Pathol 2004;57:344-5.